Market revenue in 2023 | USD 77.3 million |
Market revenue in 2030 | USD 140.9 million |
Growth rate | 9% (CAGR from 2023 to 2030) |
Largest segment | Regulatory writing & publishing |
Fastest growing segment | Regulatory Consulting |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Other Services |
Key market players worldwide | Labcorp Holdings Inc, Icon PLC, IQVIA Holdings Inc, Intertek Group PLC, SGS AG, Promedica International, Integer Holdings Corp, Medpace Holdings Inc, Emergo Group, Freyr Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device regulatory affairs market will help companies and investors design strategic landscapes.
Regulatory writing & publishing was the largest segment with a revenue share of 53.3% in 2023. Horizon Databook has segmented the Mexico medical device regulatory affairs market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is the second-largest medical device market in Latin America and is also expected to showcase significant growth in the medical device regulatory affairs market during the forecast period. The low cost of manufacturing is expected to attract global medical device companies to this country.
Furthermore, migration from all other Latin American countries has increased the workforce in Mexico. As a result, Mexico has a favorable workforce supply and demand ratio, thus, it has stable labor rates for medical device manufacturing.
Proximity to the U.S. is also expected to reduce the monitoring cost of medical device firms. This trend is expected to significantly contribute to the growth of the country's medical device regulatory affairs market. Some key players operating in the country are PharmaLex Mexico, Reguliance, SI Group, MKG Regulatory Consulting, and GSF Consultores.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico medical device regulatory affairs market , including forecasts for subscribers. This country databook contains high-level insights into Mexico medical device regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account